Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-Analysis

<div>Forest map of summary estimates for comparison of virological suppression between TDF-based combination therapy and monotherapy groups. (a) 24 weeks; (b) 48 weeks; (c) 96 weeks.</div>

Gastroenterology Research and Practice

fig2

Figure 2

Figure 2: Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-Analysis 

Figure 2 | Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-Analysis 